Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.
about
Implications of GABAergic Neurotransmission in Alzheimer's DiseaseNew Insights on Astrocyte Ion Channels: Critical for Homeostasis and Neuron-Glia SignalingElusive roles for reactive astrocytes in neurodegenerative diseasesAcupuncture for neurogenesis in experimental ischemic stroke: a systematic review and meta-analysisDefining the earliest pathological changes of Alzheimer's diseaseAltered GABAergic Signaling in Brain Disease at Various Stages of Life.Functional Characterization of Resting and Adenovirus-Induced Reactive Astrocytes in Three-Dimensional Culture.GABA as a rising gliotransmitterHIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismPlaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease.Anxiety is associated with increased risk of dementia in older Swedish twins.APP modulates KCC2 expression and function in hippocampal GABAergic inhibition.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Methylene blue inhibits GABAA receptors by interaction with GABA binding site.Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis.Human astrocytes in the diseased brain.Context-Dependent Modulation of GABAAR-Mediated Tonic Currents.Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy.Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Reduced tonic inhibition in the dentate gyrus contributes to chronic stress-induced impairments in learning and memory.Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.Hippocampal GABA enables inhibitory control over unwanted thoughts.Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition.Prefrontal Cortical GABAergic Dysfunction Contributes to Aberrant UP-State Duration in APP Knockout Mice.Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia.Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice.Reactive Astrocytes as Drug Target in Alzheimer's Disease.Deciphering the Astrocyte Reaction in Alzheimer's Disease.Inflammation as a central mechanism in Alzheimer's diseaseLoss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain
P2860
Q26768593-35B0EB39-EEBD-43E7-B81A-F0D87FDD71F1Q26782952-6C565853-1AF5-47BF-B658-E0751C60D4E4Q26797399-F08D14FB-F192-4C43-9EBD-A8128AAD421DQ28078885-5410D5D4-8306-4B47-B1CE-281B5FEC95D8Q28081435-1B6562B0-7926-4952-840A-908000FAF5C1Q33854558-168C7CEB-101F-4EC4-A240-C622ACC4748BQ33854575-C8BC93F5-4DDF-4647-BAF8-8DB778F9A6ACQ34722127-28C8B93C-B9FD-4ECB-AB44-20FA22BAC8C8Q35007551-E90871E0-60E6-4524-AEB8-96E8C59ABA42Q36509219-4DF8A14B-6EBB-48B4-8D8B-F7F81E5CAB80Q36827317-872091F2-5F2B-47A6-8E8E-C834D09390F0Q37578029-F0F3F261-7423-43F1-854A-EFD9B773EE94Q38733357-81CB2D2B-CCB8-4E53-BF8D-E53865A80DF0Q38846389-10F75B27-6F82-4911-BCC8-69231D208F1DQ38933657-4B88D36B-9B92-4A3A-8E8F-DF4CBB515EEBQ39141123-342C395C-5FFE-4A0E-AEF1-99BDF3EEDCEEQ40116043-C57DC28A-7C34-4FFC-B387-2DA4B1F979FDQ40321458-38BC697D-CBF7-4A9E-9FDA-4351F7ADFC96Q41085679-E1B768A1-BE46-40B4-9101-51DC1785A269Q41574564-A581CBA6-4E61-4E9E-9DDF-1E104F6FEF4AQ41643247-301B04EB-7CD0-444F-BDDE-1FCF42F08CC3Q42373554-5F99C4C6-B4CE-45D2-BABF-66FA12918F98Q46129049-0FC5B086-482C-476F-B8D4-4F8A6AA6FF6FQ47157251-E15EEBC3-D499-4698-B126-888E42694E6AQ47163345-85CF1E7E-54A8-4DE4-9F67-D135EE8BEE12Q47822876-74B5F84E-3DA3-4374-AC0A-FBD90B40B645Q47964876-F398915D-7B03-4FBB-BD04-FBCE41B33C3FQ54945993-6F5F531B-3B89-4A9C-9C3F-75E2617F349FQ55280382-BD3860B8-91B5-411B-B579-E4FF2B686ADBQ55364689-9025C945-20F6-48A4-B3A2-34C1DD26DD24Q58555818-D0DD6CC0-B69A-4489-BC21-F7B9B8122095Q58778218-DD064CF9-C3AD-4E55-8A63-C5C9C824C6A4
P2860
Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@ast
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@en
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@nl
type
label
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@ast
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@en
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@nl
prefLabel
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@ast
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@en
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@nl
P2093
P2860
P356
P1476
Tonic inhibition in dentate gy ...... r's [corrected] disease model.
@en
P2093
Marla Gearing
Ziyuan Guo
P2860
P2888
P356
10.1038/NCOMMS5159
P407
P577
2014-06-13T00:00:00Z
P5875
P6179
1040232897